JAMDA
September 1, 2017
Showing 111 - 120 of 2611 results
JAMDA
July 26, 2016
Prevalence of Potentially Inappropriate Medication Use in Older Adults Living in Nursing Homes: A Systematic Review
As older adults living in nursing homes are at a high risk of adverse drug-related events, medications with a poor benefit/risk ratio or with a safer alternative should be avoided.
JAMDA
March 24, 2016
Patterns of Emergency Department Use Among Long-Stay Nursing Home Residents With Differing Levels of Dementia Severity
To describe emergency department (ED) utilization among long-stay nursing home residents with different levels of dementia severity.
JAMDA
September 16, 2019
Antibiograms Cannot Be Used Interchangeably Between Acute Care Medical Centers and Affiliated Nursing Homes
To determine whether antibiograms for Veterans Affairs (VA) nursing homes (NHs), termed Community Living Centers, are similar to those from their affiliated acute care medical centers.
Policy Snapshot
June 16, 2025
OIG Report Finds CMS Staffing Data Use Falls Short in Supporting State Oversight of Nursing Homes
A recent review by the Office of Inspector General (OIG) highlights gaps in how CMS supports state oversight of nursing home staffing. While CMS has provided new data tools to help states monitor staffing levels, including the Payroll Based Journal (PBJ) system, the report finds that crucial information is...
JAMDA
October 6, 2021
Modest Association between Antibiotic and Antipsychotic Prescribing Rates in Nursing Homes
JAMDA
February 7, 2014
Point Prevalence of Risk: Combined Effects of Antipsychotics, Antidepressants, Anxiolytics, Narcotics and Sedative-hypnotics on Falls in a Nursing Home Long Term Care Unit. An Interdisciplinary Team Approach to Patient Safety and Quality Improvement
JAMDA
November 16, 2017
Efficacy and Safety of Citalopram Compared With Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia
JAMDA
July 21, 2017
Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia
To assess efficacy and safety of citalopram compared to quetiapine and olanzapine for the treatment of agitation in patients with Alzheimer disease (AD).
JAMDA
February 26, 2020